ADHD

Seventeen million children and adults in the United States are currently living with ADHD. Each October, ADHD Awareness Month is celebrated with different events, activities, and resources to continue shining the light on the disorder.

An analysis of previous studies of children and young adults with ADHD has quantified the extent to which stimulant treatment reduces the development of mood disorders, problems in school, conduct disorders, substance use disorders, and other problems.

The study included an analysis detailing crash and traffic violation records for newly licensed drivers. It is the first large-scale longitudinal study on this topic.

It is critical to stress that Attention-Deficit/Hyperactivity Disorder is probably a lifelong condition for most individuals with the condition.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The prescription of stimulants for the treatment of attention deficit-hyperactivity disorder (ADHD) is increasing among adolescents and young adults, and a new study sheds light on possible safety concerns.

The drug's approval was based on 4 clinical studies evaluating the efficacy and safety of Adhansia XR in 883 people who met DSM-5 criteria for ADHD.

Within the group of Spanish patients with ADHD, a specific variation of the LPHN3 gene increased by 40% the risk of nicotine dependence.

Under the settlement and license agreement, Neos has granted Teva the right to manufacture and market its generic version of Cotempla XR-ODT® under the Teva ANDA beginning on July 1, 2026, or earlier under certain circumstances.

Canine animal assistance improves attentiveness and social skills in children with ADHD, according to recent study.

A recent study found that athletes with attention deficit hyperactivity disorder (ADHD) may need to be even more cautious in concussion prevention.

Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders.

New research suggests psychiatric diseases that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.

New research suggests psychiatric diseases, including ADHD, that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.

Prescription medication use for attention-deficit/hyperactivity disorder (ADHD), asthma, and contraception have all increased in children and teens.

Attention-deficit/hyperactivity disorder is a neurodevelopmental mental disorder characterized by difficulty paying attention, excessive activity, and/or impulsivity that interferes with development and/or functioning.

Many patients with ADHD report peers seeking nonmedical prescription stimulant use.

More research needed to determine if ADHD medication is safe to take before and during pregnancy.

Use of drugs that treat attention-deficit/hyperactivity disorder increased among all age groups and in all US geographic regions.

Study finds that ADHD treatment recommendations are not always followed.

Acetaminophen use for 29 days or more during pregnancy linked to a significant risk of attention-deficit/hyperactivity disorder.

Top articles of the week from The American Journal of Pharmacy Benefits.

Children with ADHD treated with AKL-T01 showed a significant positive improvement in attention.